United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast

1.    Executive Summary

2.    United Kingdom Proton Therapy Market – Actual & Untapped Market
2.1    United Kingdom – Proton Therapy Market

2.2    United Kingdom – Untapped Proton Therapy Market

3.    United Kingdom Proton Therapy Patient Number – Actual and Untapped
3.1    United Kingdom – Patients Treated with Proton Therapy Actual Numbers & Forecast

3.2    United Kingdom – Patients with Proton Therapy Untapped Numbers & Forecast

4.    United Kingdom – List of Proton Therapy Centers

5.    United Kingdom – Proton Therapy Treated Patients by Centers
5.1    Clatterbridge Proton Therapy Center

6.    Proton Therapy – Reimbursement Policies
6.1    Proton Therapy Reimbursement Policies for Patients

6.2    Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

7.    Components of a Standard Proton Therapy Center
7.1    Proton Accelerator
7.1.1    Synchrotrons (example: LLUMC at Loma Linda) 
7.1.2    Cyclotrons (example: MGH Boston) 
7.1.3    Synchrocyclotrons (examples: Orsay, Uppsala) 
7.1.4    Linacs (Rome) 
7.1.5    H-minus Synchrotrons
7.1.6    Separated Sector Cyclotrons
7.1.7    Super-conducting Cyclotrons
7.1.8    Fast Cycling Synchrotron

7.2    Beam Transport System

7.3    Beam Delivery System
7.3.1    The Passive Scattering Technique
7.3.2    Beam Scanning

7.4    Nozzle
7.4.1    Single Scattering
7.4.2    Double Scattering
7.4.3    Uniform Scanning Nozzle
7.4.4    Pencil Scanning Nozzle

7.5    Treatment Planning System

7.6    Image Viewers

7.7    Patient Positioning System (PPS) 

7.8    Human Resource

8.    Global Proton Therapy - Company Analysis (2010-2021) 
8.1    IBA Proton Therapy
8.1.1    Overview
8.1.2    Sales Analysis

8.2    Varian Medical Systems
8.2.1    Overview
8.2.2    Sales Analysis

8.3    Elekta
8.3.1    Overview
8.3.2    Sales Analysis

9.    Proton Therapy – Driving Factors
9.1    Technology Advancement

9.2    Growing Incidence of Cancer Patients in United Kingdom

10.    Proton Therapy – Challenges
10.1    Requires Huge Investment

10.2    Operations Challenges

List of Figures

Figure 1 1: United Kingdom – Proton Therapy Market (Million US$), 2009 – 2016
Figure 1 2: United Kingdom – Forecast for Proton Therapy Market (Million US$), 2017 – 2021
Figure 1 3: United Kingdom – Potential Proton Therapy Market (Million US$), 2009 – 2016
Figure 1 4: United Kingdom – Forecast for Potential Proton Therapy Market (Million US$), 2017 – 2021

Figure 2 1: United Kingdom – Patient Treated with Proton Therapy (Number), 2009 – 2016
Figure 2 2: United Kingdom – Patient Treated with Proton Therapy (Number), 2017 – 2021
Figure 2 3: United Kingdom – Potential Patient for Proton Therapy (Number), 2009 – 2016
Figure 2 4: United Kingdom – Forecast for Potential Patient for Proton Therapy (Number), 2007 – 2021

Figure 7 1: Global – IBA Proton Therapy Sales (Million US$), 2010 – 2016
Figure 7 2: Global – Forecast for IBA Proton Therapy Sales (Million US$), 2017 – 2021
Figure 7 3: Global – Varian Medical Systems Oncology Systems Sales (Million US$), 2010 – 2016
Figure 7 4: Global – Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 – 2021
Figure 7 5: Global – Elekta Radiation Technology Sales (Million US$), 2010 – 2016
Figure 7 6: Global – Forecast for Elekta Radiation Technology Sales (Million US$), 2017 – 2021

Figure 8 1: United Kingdom – Number of Patient Diagnosed With Cancer (Thousand), 2009 – 2016
Figure 8 2: United Kingdom – Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2017 – 2021

List of Tables

Table 3 1: United Kingdom – Proton Therapy Facilities in Operation and in Development Phase

Table 4 1: United Kingdom – Clatterbridge Proton Therapy Center with Patients Treated (Number), 2008 – 2015